Anna Zelenaya | Computer-aided materials | Best Researcher Award

Posted on by ScienceFather

🌟Dr. Anna Zelenaya, Computer-aided materials, Best Researcher Award🏆

Doctorate at The organization name: Institute of Physical Materials Science of Siberian Branch of Russian Academy of Sciences, Russia

Dr. Zelenaya Anna Eduardovna is a senior research fellow with a Ph.D. at the Institute of Physical Materials Science of the Siberian Branch of the Russian Academy of Sciences in Ulan-Ude. Her research primarily focuses on computer simulation of phase diagrams of multicomponent systems to develop new materials with predictable properties. With over two decades of experience, she has made significant contributions to the field through her publications, patents, and participation in scientific projects.

Author Metrics

Scopus Profile

ORCID Profile

Throughout her career, Dr. Zelenaya has authored 45 publications indexed in international databases. She has also obtained 2 patents, demonstrating her innovative contributions to materials science. Additionally, she has participated in and led 11 scientific projects, showcasing her expertise and leadership in the field.

  • Citations: 113 citations from 64 documents.
  • Documents: Zelenaya A. E. has 45 documents published.
  • h-index: The h-index, a measure of productivity and citation impact, is 6 for Zelenaya A. E.

Education

Dr. Zelenaya completed her graduate studies at the Department of Physical Problems, Buryat Scientific Center (Siberian Branch of the Russian Academy of Sciences), where she earned her Ph.D. She also holds a degree in Physics and Mathematics from Buryat State University named after D. Banzarov.

Research Focus

Dr. Zelenaya’s research focuses on computer simulation of phase diagrams of multicomponent systems. She aims to develop new materials with predictable properties by understanding phase equilibria and crystallization stages for various compositions. Her work has applications in glass development, building materials, refractory-slag interactions, and understanding the crystallization processes of igneous rocks.

Professional Journey

Since 2001, Dr. Zelenaya has been a senior research fellow at the Institute of Physical Materials Science of the Siberian Branch of the Russian Academy of Sciences. Over the years, she has led and participated in various scientific projects, contributing to the advancement of materials science. Her expertise in computer modeling of phase diagrams has earned her recognition in the field.

Honors & Awards

Dr. Zelenaya has received recognition for her contributions to materials science, although specific honors and awards are not mentioned in the provided information.

Publications Noted & Contributions

Dr. Zelenaya’s notable publications include studies on various systems such as LiF-NaF-CaF2-LaF3, ZrO2-SiO2-Al2O3, CaO-MgO-Al2O3, Fe-Ni-Co-Cu, Co-Cu-CoS-Cu2S, titanium-aluminum-silicon-zirconium oxides, Cu-Ni-Mn, ZrO2-SiO2-Al2O3, and Ag-Au-Sb. Her research contributions include developing computer models of phase diagrams, resolving experimental data contradictions, and predicting phase equilibria.

The Sm<sub>2</sub>S<sub>3-X</sub>-SmS-Sm<sub>2</sub>O<sub>2</sub>S refractory system: thermal analysis, phase diagram, and properties of the phases

  • Journal: Journal of Thermal Analysis and Calorimetry
  • Year: 2024
  • DOI: 10.1007/S10973-023-12792-Z
  • Contributors: Yurev, Ilya Olegovich; Aleksandrovsky, Aleksandr Sergeevich; Kamaev, Dmitriy Nikolaevich; Polkovnikov, Aleksei Aleksandrovich; Grigorchenko, Viktoriya Maksimovna; Yarovenko, Aleksandr Aleksandrovich; Zelenaya, Anna Eduardovna; Parfenova, Mariya Dmitriyevna; Andreev, Oleg Valeryevich

Creating a digital passport based on the spatial computer model of the isobaric phase diagram for the Ag-Au-Sb system

  • Journal: Materials Science and Engineering: B
  • Year: 2024-06
  • DOI: 10.1016/j.mseb.2024.117365
  • Contributors: Anna Zelenaya; Vera Vorob’eva; Vasily Lutsyk; Maria Parfenova

Correction of the 3D Computer Model of the Phase Diagram for the LiCl-PrCl<sub>3</sub>-KCl System Using Thermoanalytical Curves

  • Journal: Russian Journal of Inorganic Chemistry
  • Year: 2023
  • DOI: 10.1134/S0036023623601174
  • Contributors: Vorob’eva, V. P.; Zelenaya, A. E.; Lutsyk, V. I.; Parfenova, M. D.; Baldanov, V. D.

Spatial Computer Model of the UCl<sub>3</sub>-NaCl-MgCl<sub>2</sub>-PuCl<sub>3</sub> Isobaric Phase Diagram

  • Journal: Russian Journal of Inorganic Chemistry
  • Year: 2023
  • DOI: 10.1134/S0036023623602039
  • Contributors: Vorob’eva, V. P.; Zelenaya, A. E.; Lutsyk, V. I.; Lamueva, M. V.

State Diagram of the ZrO<sub>2</sub>-SiO<sub>2</sub>-Al<sub>2</sub>O<sub>3</sub> System with Visualization by Computer 3D-Model and Calculation Using the NUCLEA Database

  • Journal: Doklady Physical Chemistry
  • Year: 2023
  • DOI: 10.1134/S0012501623600079
  • Contributors: Vorob’eva, V. P.; Zelenaya, A. E.; Lutsyk, V. I.; Vorozhtcov, V. A.; Almjashev, V. I.; Stolyarova, V. L.

Research Timeline

Dr. Zelenaya’s research timeline spans over two decades, starting from her graduate studies in the late 1990s to her current position as a senior research fellow. Over this period, she has continuously contributed to the field through her research, publications, and participation in scientific projects.

Collaborations and Projects

Dr. Zelenaya has been involved in various scientific projects, including the modernization of technological processes in nickel, cobalt, and copper production. She has also collaborated on projects focusing on the development of advanced materials for nuclear reactor fuel rods. These collaborations demonstrate her interdisciplinary approach and her ability to work on diverse scientific endeavors.

Guohai Zhang | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

🌟Dr. Guohai Zhang, Medicinal Chemistry, Young Scientist Award🏆

Doctorate at Guangxi Normal University, China

Guo-Hai Zhang is an Associate Professor at the State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University. His research primarily focuses on targeted therapy and drug resistance mechanisms in lung cancer. He has made significant contributions to understanding the role of wild-type EGFR and p53 in non-small cell lung cancer (NSCLC), as well as the molecular basis of p53 mitochondrial localization. Guo-Hai Zhang has conducted numerous research projects funded by the National Natural Science Foundation of China (NSFC) and Guangxi NSFC, resulting in 20 SCI papers published in reputable journals.

Author Metrics

Scopus Profile

Guo-Hai Zhang has authored or co-authored 20 SCI papers published in journals such as J Med Chem, J Biol Chem, Biochem Pharmacol, and Eur J Med Chem. These publications demonstrate his impact and recognition in the field of lung cancer research, particularly in understanding targeted therapy and drug resistance mechanisms.

Citations: 566 citations by 514 documents

Documents: 27

h-index: 14

Education

Guo-Hai Zhang pursued his Ph.D. in the medical field at Nanjing University. Prior to that, he obtained a Master’s degree from Huaqiao University and a Bachelor’s degree from Shandong University of Science and Technology, both focusing on molecular medicine and chemistry.

Research Focus

Guo-Hai Zhang’s research primarily focuses on targeted therapy and drug resistance mechanisms in lung cancer, particularly non-small cell lung cancer (NSCLC). His work includes elucidating the role of wild-type EGFR and p53 in NSCLC, understanding the molecular mechanisms underlying drug resistance, and exploring intervention methods to overcome resistance.

Professional Journey

Guo-Hai Zhang’s professional journey began as a Research Associate at the State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, where he conducted research from 2011 to 2017. Since December 2017, he has held the position of Associate Professor at the same institution, continuing his research in targeted therapy and drug resistance mechanisms in lung cancer.

Honors & Awards

Guo-Hai Zhang’s contributions to the field of lung cancer research have earned him recognition and honors, although specific awards and honors are not mentioned in the provided information.

Publications Noted & Contributions

Guo-Hai Zhang has made notable contributions to the field of lung cancer research through his publications. Some of his key contributions include elucidating the role of wild-type EGFR and p53 in NSCLC, understanding the molecular mechanisms of drug resistance, and exploring intervention methods to overcome resistance. His research findings have been published in reputable journals such as J Med Chem, J Biol Chem, Biochem Pharmacol, and Eur J Med Chem.

Title: Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation
Authors: Li, L., Du, W., Wang, H., …, Zeng, S., Zhang, G.
Journal: Chemico-Biological Interactions, 2022, 366, 110142
Citations: 1

Title: Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation
Authors: Li, L., Li, P., Ma, X., …, Peng, Y., Zhang, G.
Journal: Biochemical Pharmacology, 2022, 203, 115188
Citations: 3

Title: Axl Mediates Resistance to Respiratory Syncytial Virus Infection Independent of Cell Attachment
Authors: Zhang, D., Zhao, Y., Wang, L., …, He, S., Li, E.
Journal: American Journal of Respiratory Cell and Molecular Biology, 2022, 67(2), pp. 227–240
Citations: 1

Title: Targeting entry into mitochondria for increased anticancer efficacy of BCL-XL-selective inhibitors in lung cancer
Authors: Li, L., Li, P., Song, H., …, Peng, Y., Zhang, G.
Journal: Pharmacological Research, 2022, 177, 106095
Citations: 2

Title: Glycyrrhizic acid inhibits SARS-CoV-2 infection by blocking spike protein-mediated cell attachment
Authors: Li, J., Xu, D., Wang, L., …, Li, E., He, S.
Journal: Molecules, 2021, 26(20), 6090
Citations: 32

Research Timeline

Guo-Hai Zhang’s research timeline spans from his tenure as a Research Associate from 2011 to 2017 to his current position as an Associate Professor, which he has held since December 2017. Throughout this time, he has been actively involved in conducting research projects funded by the National Natural Science Foundation of China (NSFC) and Guangxi NSFC.

Collaborations and Projects

Guo-Hai Zhang has collaborated on various research projects focused on targeted therapy and drug resistance mechanisms in lung cancer. His research group has conducted projects funded by the National Natural Science Foundation of China (NSFC) and Guangxi NSFC, contributing to the understanding of lung cancer biology and the development of targeted therapies.